BKR Stock Analysis: Baker Hughes | NASDAQ
Oil & Gas Equipment & Services | NASDAQ, USA | Market Cap: 52.361m USD | 12M Return: 46.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 520M
EPS Trend: 97.0%
Qual. Beats: 4
Rev. Trend: 86.3%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Baker Hughes Company (BKR) is a Houston-based energy and industrial technology provider operating through two main segments. Its Oilfield Services & Equipment segment supplies products and services across the full well lifecycle-from exploration and drilling through production, intervention, and decommissioning-serving oil and gas operators, national oil companies, EPC contractors, and geothermal firms. The Industrial & Energy Technology segment offers gas compression and power generation equipment, non-destructive testing and asset monitoring technologies (including its Bently Nevada and Cordant product lines), flow control solutions, and climate technology offerings for industrial, upstream, midstream, and downstream customers. The company was formed through the 2017 merger of Baker Hughes with GE Oil & Gas and rebranded from Baker Hughes, a GE company to its current name in October 2019. Baker Hughes is generally regarded as one of the three largest diversified oilfield service providers globally, competing alongside SLB and Halliburton in a sector whose demand is closely tied to global oil and gas capital expenditure and commodity price cycles.
- North American shale activity drives Oilfield Services revenue
- International E&P capex growth boosts Middle East orders
- LNG demand fuels Industrial Energy Technology gas turbine orders
| Net Income: 3.12b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.78 > 1.0 |
| NWC/Revenue: 54.42% < 20% (prev 15.26%; Δ 39.16% < -1%) |
| CFO/TA 0.07 > 3% & CFO 3.60b > Net Income 3.12b |
| Net Debt (1.50b) to EBITDA (5.10b): 0.29 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (996.0m) vs 12m ago -0.30% < -2% |
| Gross Margin: 23.57% > 18% (prev 22.81%; Δ 0.75% > 0.5%) |
| Asset Turnover: 62.68% > 50% (prev 73.05%; Δ -10.37% > 0%) |
| Interest Coverage Ratio: 14.97 > 6 (EBIT TTM 3.85b / Interest Expense TTM 257.0m) |
| A: 0.30 (Total Current Assets 28.6b - Total Current Liabilities 13.4b) / Total Assets 50.9b |
| B: -0.05 (Retained Earnings -2.32b / Total Assets 50.9b) |
| C: 0.09 (EBIT TTM 3.85b / Avg Total Assets 44.5b) |
| D: 0.61 (Book Value of Equity 19.3b / Total Liabilities 31.4b) |
| Altman-Z'' = 3.03 = A |
| DSRI: 1.00 (Receivables 6.70b/6.71b, Revenue 27.9b/27.8b) |
| GMI: 0.97 (GM 22.81% / 23.57%) |
| AQI: 0.78 (AQ_t 0.33 / AQ_t-1 0.42) |
| SGI: 1.00 (Revenue 27.9b / 27.8b) |
| TATA: -0.01 (NI 3.12b - CFO 3.60b) / TA 50.9b) |
| Beneish M = -3.19 (Cap -4..+1) = AA |
As of July 14, 2026, the stock is trading at USD 57.66 with a total of 5,668,418 shares traded. Over the past week, the price has changed by +9.06%, over one month by -8.84%, over three months by -7.68% and over the past year by +46.86%.
Current recommended Stop Loss: 55.30 (which is 4.1% or 1.3 ATR below the current price).
Baker Hughes has received a consensus analysts rating of 4.26. Therefore, it is recommended to buy BKR.
- StrongBuy: 12
- Buy: 10
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 71.2 | 23.6% |
P/E Trailing = 16.8626
P/E Forward = 19.9203
P/S = 1.8772
P/B = 2.7111
P/EG = 2.1188
Revenue TTM = 27.9b USD
EBIT TTM = 3.85b USD
EBITDA TTM = 5.10b USD
Long Term Debt = 15.4b USD (from longTermDebt, last quarter)
Short Term Debt = 753.0m USD (from shortTermDebt, last quarter)
Debt = 16.3b USD (from shortLongTermDebtTotal, last quarter) + Leases 103.0m
Net Debt = 1.50b USD (calculated: Debt 16.3b - CCE 14.8b)
Enterprise Value = 53.9b USD (52.4b + Debt 16.3b - CCE 14.8b)
Interest Coverage Ratio = 14.97 (Ebit TTM 3.85b / Interest Expense TTM 257.0m)
EV/FCF = 23.50x (Enterprise Value 53.9b / FCF TTM 2.29b)
FCF Yield = 4.26% (FCF TTM 2.29b / Enterprise Value 53.9b)
FCF Margin = 8.22% (FCF TTM 2.29b / Revenue TTM 27.9b)
Net Margin = 11.17% (Net Income TTM 3.12b / Revenue TTM 27.9b)
Gross Margin = 23.57% ((Revenue TTM 27.9b - Cost of Revenue TTM 21.3b) / Revenue TTM)
Gross Margin QoQ = 22.83% (prev 23.73%)
Tobins Q-Ratio = 1.06 (Enterprise Value 53.9b / Total Assets 50.9b)
Interest Expense / Debt = 1.58% (Interest Expense 257.0m / Debt 16.3b)
Taxrate = 12.17% (437.0m / 3.59b)
NOPAT = 3.38b (EBIT 3.85b * (1 - 12.17%))
Current Ratio = 2.13 (Total Current Assets 28.6b / Total Current Liabilities 13.4b)
Debt / Equity = 0.84 (Debt 16.3b / totalStockholderEquity, last quarter 19.3b)
Debt / EBITDA = 0.29 (Net Debt 1.50b / EBITDA 5.10b)
Debt / FCF = 0.66 (Net Debt 1.50b / FCF TTM 2.29b)
Total Stockholder Equity = 18.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.00% (Net Income 3.12b / Total Assets 50.9b)
RoE = 16.84% (Net Income TTM 3.12b / Total Stockholder Equity 18.5b)
RoCE = 11.34% (EBIT 3.85b / Capital Employed (Equity 18.5b + L.T.Debt 15.4b))
RoIC = 9.17% (NOPAT 3.38b / Invested Capital 36.8b)
WACC = 7.23% (E(52.4b)/V(68.6b) * Re(9.04%) + D(16.3b)/V(68.6b) * Rd(1.58%) * (1-Tc(0.12)))
Discount Rate = 9.04% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -69.01 | Cagr: -0.62%
[DCF] Terminal Value 77.80% ; FCFF base≈2.18b ; Y1≈2.48b ; Y5≈3.56b
[DCF] Fair Price = 52.59 (EV 53.7b - Net Debt 1.50b = Equity 52.2b / Shares 992.1m; r=8.35% [WACC [floored]]; 5y FCF grow 13.92% → 2.50% )
EPS Correlation: 96.97 | EPS CAGR: 31.82% | SUE: 4.0 | # QB: 4
Revenue Correlation: 86.34 | Revenue CAGR: 5.77% | SUE: 1.13 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.48 | Chg30d=+1.33% | Revisions=-25% | Analysts=15
EPS next Quarter (2026-09-30): EPS=0.55 | Chg30d=+0.27% | Revisions=+0% | Analysts=13
EPS current Year (2026-12-31): EPS=2.31 | Chg30d=+0.56% | Revisions=+0% | GrowthEPS=-11.2% | GrowthRev=-2.0%
EPS next Year (2027-12-31): EPS=2.77 | Chg30d=-0.52% | Revisions=+0% | GrowthEPS=+19.9% | GrowthRev=+6.4%
[Analyst] Revisions Ratio: -25% (up=0, down=1)